Akoya to Participate at Three Upcoming Investor Conferences

Rhea-AI Summary

Akoya Biosciences (Nasdaq: AKYA) announces participation in three key investor conferences. The company will present at the Bank of America 2022 Healthcare Conference on May 10, 2022, at 10:40 AM PT, followed by a fireside chat at the UBS Global Life Science Conference on May 23, 2022, at 7:45 AM ET. Additionally, Akoya will have a virtual presentation available on-demand from May 24-26, 2022, during the HC Wainwright Global Investment Conference. Archived webcasts can be accessed on Akoya’s website.

News Market Reaction – AKYA

+4.45%

+4.45% Session move

In the trading session that priced this news, AKYA gained 4.45%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MARLBOROUGH, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in three upcoming investor conferences.

• Bank of America 2022 Healthcare Conference
  Presentation on Tuesday, May 10^th at 10:40 AM PT
  

• UBS Global Life Science Conference
  Fireside chat on Monday, May 23^rd at 7:45 AM ET
  

• HC Wainwright Global Investment Conference
  Virtual Presentation available on-demand May 24-26
  

Live and archived webcasts of the events will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company^®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

FAQ

What is Akoya Biosciences' participation in investor conferences in May 2022?

Akoya Biosciences will participate in the Bank of America 2022 Healthcare Conference on May 10, UBS Global Life Science Conference on May 23, and have a virtual presentation at the HC Wainwright Global Investment Conference from May 24-26.

When will Akoya Biosciences present at the Bank of America 2022 Healthcare Conference?

Akoya Biosciences will present at the Bank of America 2022 Healthcare Conference on May 10, 2022, at 10:40 AM PT.

What events will Akoya participate in on May 23, 2022?

On May 23, 2022, Akoya will take part in a fireside chat at the UBS Global Life Science Conference at 7:45 AM ET.

How can investors access Akoya's presentations from the conferences?

Investors can access live and archived webcasts of Akoya's presentations on the 'Investors' section of the Akoya website.

What is the focus of Akoya Biosciences as The Spatial Biology Company?

Akoya focuses on spatial phenotyping, offering single-cell imaging solutions to help researchers understand cellular interactions in the context of biology and disease.